Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is Rp 20.671.102,49, with a 24-hour trading volume of Rp 25,37T. The asset's market cap is Rp 18,42P, after moving -2.20% in the last day.
Tokenized Eli Lilly And Co is trading at Rp 20.781.881,87, with a tokenized market cap of Rp 810,14B and a 24-hour trading volume of Rp 33,25B. The tokenized asset has moved -1.77% in the past 24 hours.